Theralase Technologies Inc. has closed its previously announced public offering of units. On closing, the corporation issued an aggregate of 18,181,817 units at a price of 44 cents per unit for aggregate gross proceeds of approximately $8-million. Each unit consists of one common share of the corporation and one common share purchase warrant. Each warrant entitles the holder to acquire an additional common share at a price of 54 cents for a period of 60 months following the date of issuance.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.